Esgen Llc - Oct 19, 2021 Form 3 Insider Report for ESGEN Acquisition Corp (ESAC)

Role
10%+ Owner
Signature
/s/ Andrea Bernatova, as Attorney-in-Fact
Stock symbol
ESAC
Transactions as of
Oct 19, 2021
Transactions value $
$0
Form type
3
Date filed
10/19/2021, 08:03 PM
Next filing
Oct 22, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ESAC Class B ordinary shares Oct 19, 2021 Class A ordinary shares 4.57M Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As described in the issuer's registration statement on Form S-1 (File No. 333-259836) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock, par value $0.0001 per share, will automatically convert into shares of Class A common stock, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date.
F2 The shares of Class B common stock owned by the reporting person include up to 675,425 shares that are subject to forfeiture if the underwriters of the initial public offering do not exercise in full their over-allotment option as described in the issuer's registration statement.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney. ESGEN LLC ("Sponsor") is controlled by a board of managers that consists of Andrejka Bernatova, Michael C. Mayon and James P. Benson. Ms. Bernatova and Messrs. Mayon and Benson have voting and investment discretion with respect to the securities held by the reporting person and may be deemed to have shared beneficial ownership of the securities held by the reporting person. The business address of each of these individuals is c/o ESGEN LLC, 5956 Sherry Lane Suite 1400